Insmed Incorporated (INSM) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Insmed Incorporated (INSM) Bundle
Discover the true potential of Insmed Incorporated (INSM) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how changes affect Insmed Incorporated (INSM) valuation – all within one Excel template.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 136.5 | 164.4 | 188.5 | 245.4 | 305.2 | 373.6 | 457.4 | 560.0 | 685.5 | 839.3 |
| Revenue Growth, % | 0 | 20.48 | 14.63 | 30.19 | 24.39 | 22.42 | 22.42 | 22.42 | 22.42 | 22.42 |
| EBITDA | -215.7 | -250.4 | -375.1 | -429.4 | -654.7 | -373.6 | -457.4 | -560.0 | -685.5 | -839.3 |
| EBITDA, % | -158.04 | -152.28 | -199.03 | -175.03 | -214.52 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 10.2 | 20.1 | 27.8 | 24.3 | 10.6 | 35.7 | 43.7 | 53.5 | 65.5 | 80.2 |
| Depreciation, % | 7.46 | 12.21 | 14.78 | 9.89 | 3.47 | 9.56 | 9.56 | 9.56 | 9.56 | 9.56 |
| EBIT | -225.9 | -270.5 | -402.9 | -453.7 | -665.3 | -373.6 | -457.4 | -560.0 | -685.5 | -839.3 |
| EBIT, % | -165.5 | -164.5 | -213.81 | -184.92 | -217.99 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 487.4 | 532.8 | 716.8 | 1,148.3 | 780.4 | 373.6 | 457.4 | 560.0 | 685.5 | 839.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 19.2 | 16.6 | 24.4 | 29.7 | 41.2 | 46.8 | 57.4 | 70.2 | 86.0 | 105.2 |
| Account Receivables, % | 14.09 | 10.07 | 12.92 | 12.11 | 13.5 | 12.54 | 12.54 | 12.54 | 12.54 | 12.54 |
| Inventories | 28.3 | 49.6 | 67.0 | 69.9 | 83.2 | 106.3 | 130.1 | 159.3 | 195.0 | 238.8 |
| Inventories, % | 20.75 | 30.16 | 35.56 | 28.5 | 27.28 | 28.45 | 28.45 | 28.45 | 28.45 | 28.45 |
| Accounts Payable | 13.2 | 42.9 | 35.8 | 50.5 | 65.4 | 72.3 | 88.5 | 108.3 | 132.6 | 162.3 |
| Accounts Payable, % | 9.66 | 26.06 | 18.99 | 20.57 | 21.43 | 19.34 | 19.34 | 19.34 | 19.34 | 19.34 |
| Capital Expenditure | -42.3 | -6.8 | -7.3 | -9.9 | -13.3 | -35.4 | -43.3 | -53.1 | -64.9 | -79.5 |
| Capital Expenditure, % | -30.97 | -4.15 | -3.87 | -4.03 | -4.35 | -9.47 | -9.47 | -9.47 | -9.47 | -9.47 |
| Tax Rate, % | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 | -0.34203 |
| EBITAT | -226.5 | -271.7 | -401.3 | -455.0 | -667.6 | -373.3 | -457.1 | -559.5 | -685.0 | -838.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -293.0 | -247.4 | -413.0 | -434.2 | -680.2 | -394.8 | -474.8 | -581.2 | -711.6 | -871.1 |
| WACC, % | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2,253.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -889 | |||||||||
| Terminal Value | -11,988 | |||||||||
| Present Terminal Value | -7,645 | |||||||||
| Enterprise Value | -9,899 | |||||||||
| Net Debt | 722 | |||||||||
| Equity Value | -10,620 | |||||||||
| Diluted Shares Outstanding, MM | 140 | |||||||||
| Equity Value Per Share | -75.63 |
What You Will Receive
- Flexible Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Insmed Incorporated’s financial data pre-loaded to facilitate your analysis.
- Automated DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically for you.
- Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive Financial Insights: Gain access to precise historical data and future forecasts for Insmed Incorporated (INSM).
- Tailored Projection Inputs: Modify highlighted fields such as WACC, growth rates, and profit margins to suit your analysis.
- Real-Time Calculations: Experience automatic updates for DCF, Net Present Value (NPV), and cash flow evaluations.
- Interactive Dashboard: Utilize intuitive charts and summaries to effectively visualize your valuation outcomes.
- Designed for All Users: A user-friendly layout catered to investors, CFOs, and consultants alike.
How It Works
- Download: Obtain the pre-built Excel file containing Insmed Incorporated’s (INSM) financial data.
- Customize: Modify assumptions, such as revenue projections, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various forecasts and analyze results instantly.
- Make Decisions: Leverage the valuation insights to inform your investment choices.
Why Choose This Calculator for Insmed Incorporated (INSM)?
- Designed for Experts: A specialized tool utilized by investment analysts, CFOs, and healthcare consultants.
- Accurate Financial Data: Insmed’s historical and projected financials are preloaded for precise calculations.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically calculates intrinsic value, NPV, and essential financial metrics.
- User-Friendly Interface: Step-by-step guidance ensures a smooth calculation experience.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for assessing investments in Insmed Incorporated (INSM).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations.
- Consultants and Advisors: Deliver precise valuation insights to clients interested in Insmed Incorporated (INSM) stock.
- Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling related to Insmed Incorporated (INSM).
- Healthcare Enthusiasts: Gain insights into how biotech companies like Insmed Incorporated (INSM) are valued in the financial markets.
What the Template Contains
- Pre-Filled Data: Contains Insmed Incorporated's historical financials and projections.
- Discounted Cash Flow Model: Editable DCF valuation model with real-time calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
- Key Financial Ratios: Assess Insmed's profitability, efficiency, and financial leverage.
- Customizable Inputs: Easily modify revenue growth, profit margins, and tax rates.
- Clear Dashboard: Visual representations and tables summarizing essential valuation outcomes.